Bristol-Myers Squibb Medical Imaging
This article was originally published in The Gray Sheet
Executive Summary
Imaging agent franchise recently bought out by private equity firm Avista Capital Partners for $525 million is renamed Lantheus Medical Imaging on March 18. Based in North Billerica, Mass., Lantheus is headed by President and CEO Don Kiepert (1"The Gray Sheet" Jan. 7, 2008, p. 22)
You may also be interested in...
Bristol-Myers Squibb Divests Imaging Agents, Considers Sale Of ConvaTec
Bristol-Myers Squibb is evaluating strategic alternatives for its ConvaTec ostomy and wound care device business following the divestiture of its imaging agent franchise, announced Dec. 17
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.